US-based private equity firm Gryphon Investors has made a majority investment in Water’s Edge Dermatology.

Following the deal, the management of Water’s Edge will continue to hold a significant ownership stake in the business.

Water’s Edge founder and MD Ted Schiff said: “We felt the time was right to seek a partner that shares these values and that can help us take our special brand of skincare to the next level to reach even more patients.

“We felt the time was right to seek a partner that shares these values and that can help us take our special brand of skincare to the next level.”

“We could not be more pleased and excited that Gryphon is the partner that will help move us forward together.”

Based in Florida, Water’s Edge offers comprehensive general and cosmetic dermatology, vein health and Mohs surgery, as well as radiation oncology services.

The dermatology company has more than 400 clinical experts and administrative staff to help patients with skin diseases, acne, sun damage, skin cancer and vein health issues. It also caters to patients requiring cosmetic and plastic surgery.

Gryphon partner and general manager Kevin Blank said: “We plan to accelerate growth by building upon everything that makes Water’s Edge Dermatology so successful to begin with, a team of highly trained and certified experts delivering the kind of comprehensive patient care that produces optimal outcomes.

“The company will also be the destination for other dermatologists and supporting clinicians seeking a place to practice quality medicine within a premiere system of care that seamlessly handles the increasingly complex and demanding operational, technological, financial, and regulatory requirements of managing physician offices.”